MARKET

STRO

STRO

Sutro Biopharma
NASDAQ
15.64
+1.66
+11.87%
After Hours: 15.60 -0.04 -0.26% 18:53 02/10 EST
OPEN
17.01
PREV CLOSE
13.98
HIGH
17.80
LOW
15.00
VOLUME
559.31K
TURNOVER
--
52 WEEK HIGH
20.20
52 WEEK LOW
5.23
MARKET CAP
133.24M
P/E (TTM)
-0.6020
1D
5D
1M
3M
1Y
5Y
1D
Sutro Biopharma Highlights ADC Platform in New Presentation
TipRanks · 6h ago
Sutro Biopharma Shares Rise After $110M Offering Prices
Dow Jones · 13h ago
Sutro Biopharma prices $110M common stock offering
Seeking Alpha · 16h ago
Sutro Biopharma 7.87M share Secondary priced at $13.98
TipRanks · 17h ago
Sutro Biopharma kündigt Aktienplatzierung im Volumen von 110 Millionen US-Dollar an
Reuters · 17h ago
*Sutro Biopharma to issue 7.9M Shrs at $13.98 a Shr >STRO
Dow Jones · 17h ago
*Sutro Biopharma to Use Funds for General Corporate Purposes >STRO
Dow Jones · 17h ago
*Sutro Biopharma to Raise $110M via Underwritten Offering >STRO
Dow Jones · 17h ago
More
About STRO
Sutro Biopharma, Inc. is an oncology company engaged in developing site-specific and novel-format antibody drug conjugates (ADCs), enabled by its proprietary integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. It designs and develops therapeutics using the relevant and potent modalities, including ADCs, bispecific ADCs, immunostimulatory ADCs, and dual conjugate ADCs. Enabled through its XpressCF and XpressCF+ platforms, it has entered multi-target, product-focused collaborations with pharmaceutical and biotechnology companies in the field of oncology, with its ongoing relationships that include licensing to Ipsen, on an exclusive basis, the right to research, develop, manufacture and commercialize STRO-003. STRO-003 is developed for the treatment of solid tumors. Its XpressCF and XpressCF platforms supports Vaxcyte, focused on discovery and development of vaccines for the treatment and prophylaxis of infectious disease.

Webull offers Sutro Biopharma Inc stock information, including NASDAQ: STRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STRO stock methods without spending real money on the virtual paper trading platform.